| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
47 |
| issn |
1523-3804
1534-6242 |
| issueIdentifier |
1 |
| pageRange |
43-47 |
| publicationName |
Current Atherosclerosis Reports |
| startingPage |
43 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab5e0a274224a8ef2306506b1a7df7ca
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_77cfd72825dfec1da87737baeb89ec4c |
| bibliographicCitation |
Chauffe RJ, Wilensky RL, Mohler ER. Recent Developments with Lipoprotein-Associated Phospholipase A2 Inhibitors. Current Atherosclerosis Reports. 2009 Dec 24;12(1):43–7. doi: 10.1007/s11883-009-0076-9. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a4b3921a631d086dbbe795ea92fd5ec
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_137b5aa41e820bccbfa2b8a2ddc2cea5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebe58216ead1252c830304136ef9bfe7 |
| date |
2009-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1007/s11883-009-0076-9
https://pubmed.ncbi.nlm.nih.gov/20425270
https://pubmed.ncbi.nlm.nih.gov/PMC2861789 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21922
https://portal.issn.org/resource/ISSN/1534-6242
https://portal.issn.org/resource/ISSN/1523-3804 |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Recent Developments with Lipoprotein-Associated Phospholipase A2 Inhibitors |
| discusses |
http://id.nlm.nih.gov/mesh/M0023868
http://id.nlm.nih.gov/mesh/M0012590
http://id.nlm.nih.gov/mesh/M0118406 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311264
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11263
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.1.1.4
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8596 |